Cargando…

Vaccination strategy and challenges for consolidating successful containment of covid-19 with population immunity in China

Zijian Feng and colleagues argue that sustained elimination of SARS-CoV-2 in China offers flexibility in covid-19 vaccination policy and discuss the anticipated challenges and systematic monitoring necessary to keep the immunisation component of the response on track

Detalles Bibliográficos
Autores principales:	An, Zhijie, Wang, Fuzhen, Pan, An, Yin, Zundong, Rodewald, Lance, Feng, Zijian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group Ltd. 2021
Materias:	Analysis
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8634348/ https://www.ncbi.nlm.nih.gov/pubmed/34853010 http://dx.doi.org/10.1136/bmj-2021-066125

Ejemplares similares

The National Immunization Advisory Committee in China: Roles of National Experts in Making Evidence-Based Recommendations for Immunization
por: Ma, Chao, et al.
Publicado: (2019)

Guangdong’s Study of the Effectiveness of China’s Inactivated Vaccines Against the SARS-CoV-2 B.1.617.2 (Delta) Variant
por: Wang, Fuzhen, et al.
Publicado: (2021)

Vaccinate with Confidence and Finish Strong
por: Rodewald, Lance, et al.
Publicado: (2022)

Senior Research Scholars in China CDC’s National Immunization Program
por: Wang, Miao, et al.
Publicado: (2021)

Prioritization of Vaccines for Inclusion into China’s Expanded Program on Immunization: Evidence from Experts’ Knowledge and Opinions
por: Ma, Chao, et al.
Publicado: (2022)

Rapid and sustained containment of covid-19 is achievable and worthwhile: implications for pandemic response
por: Chen, Qiulan, et al.
Publicado: (2021)

Effectiveness of Catch-Up Vaccinations after COVID-19 Containment — China, 2020
por: Wu, Jing, et al.
Publicado: (2020)

“If the world doesn’t share the vaccine, the virus will take on the world”
por: Yin, Zundong, et al.
Publicado: (2021)

Exporting China’s Successes in Vaccine Preventable Hepatitis
por: Rodewald, Lance E.
Publicado: (2020)

Effects of Three Major Immunization Interventions on Measles Control — China, 1952–2021
por: Song, Quanwei, et al.
Publicado: (2023)

Immunogenicity of two-dose and three-dose vaccination schedules with Sabin inactivated poliovirus vaccine in China: An open-label, randomized, controlled trial
por: Wang, Yamin, et al.
Publicado: (2021)

Progress Towards Hepatitis A Control and Prevention Through 2019: the National Immunization Program of China
por: Sun, Xiaojin, et al.
Publicado: (2020)

Accelerating into Immunization Agenda 2030 with momentum from China’s successful COVID-19 vaccination campaign during dynamic COVID Zero
por: Rodewald, Lance E.
Publicado: (2023)

Taiwan’s Successful COVID-19 Mitigation and Containment Strategy: Achieving Quasi Population Immunity
por: Chien, Li-Chien, et al.
Publicado: (2020)

Vaccination Guidelines During and After the COVID-19 Epidemic in China
por: Yu, Wenzhou, et al.
Publicado: (2020)

Safety, immunogenicity, and immune persistence of two inactivated COVID-19 vaccines replacement vaccination in China: An observational cohort study
por: Wang, Xiaoqi, et al.
Publicado: (2022)

Effectiveness of adenovirus type 5 vectored and inactivated COVID-19 vaccines against symptomatic COVID-19, COVID-19 pneumonia, and severe COVID-19 caused by the B.1.617.2 (Delta) variant: Evidence from an outbreak in Yunnan, China, 2021
por: Ma, Chao, et al.
Publicado: (2022)

Forty and Twenty Years Ago and Now — Virus Elimination Successes and New Challenges
por: Rodewald, Lance E.
Publicado: (2020)

Using the Consolidated Framework for Implementation Research to implement and evaluate national surgical planning
por: Saluja, Saurabh, et al.
Publicado: (2017)

Progress Toward Measles Elimination — China, January 2013–June 2019
por: Ma, Chao, et al.
Publicado: (2019)

Progress Toward Measles Elimination — China, January 2013-June 2019
por: Ma, Chao, et al.
Publicado: (2019)

Association of COVID-19 Vaccination and Clinical Severity of Patients Infected with Delta or Omicron Variants — China, May 21, 2021–February 28, 2022
por: Li, Mingshuang, et al.
Publicado: (2022)

Successes and challenges of the millennium development goals in Ethiopia: lessons for the sustainable development goals
por: Assefa, Yibeltal, et al.
Publicado: (2017)

Reforming public hospital financing in China: progress and challenges
por: Xu, Jin, et al.
Publicado: (2019)

Acute Hepatitis B — China, 2005−2019
por: Miao, Ning, et al.
Publicado: (2020)

Factors, enablers and challenges for COVID-19 vaccine development
por: Excler, Jean-Louis, et al.
Publicado: (2023)

Relative vaccine effectiveness against Delta and Omicron COVID-19 after homologous inactivated vaccine boosting: a retrospective cohort study
por: Tang, Lin, et al.
Publicado: (2022)

Effectiveness of Inactivated COVID-19 Vaccines against Delta-Variant COVID-19: Evidence from an Outbreak in Inner Mongolia Autonomous Region, China
por: Ma, Chao, et al.
Publicado: (2023)

Mobile health messaging service and helpdesk for South African mothers (MomConnect): history, successes and challenges
por: Barron, Peter, et al.
Publicado: (2018)

Factors associated with neutralizing antibody levels induced by two inactivated COVID-19 vaccines for 12 months after primary series vaccination
por: Wang, Fuzhen, et al.
Publicado: (2022)

Prevention of Chronic Hepatitis B after 3 Decades of Escalating Vaccination Policy, China
por: Cui, Fuqiang, et al.
Publicado: (2017)

Rift valley fever: diagnostic challenges and investment needs for vaccine development
por: Petrova, Velislava, et al.
Publicado: (2020)

Progress of Active Surveillance for Vaccine Safety in China
por: Liu, Zhike, et al.
Publicado: (2021)

Health technology assessment to inform decision making in China: progress, challenges, and sustainability
por: Chen, Yingyao, et al.
Publicado: (2023)

Effectiveness of DTaP Against Pertussis in ≤2-Year-Old Children — Linyi Prefecture, Shandong Province, China, 2017–2019
por: Zhu, Pinpin, et al.
Publicado: (2023)

Towards universal health coverage: achievements and challenges of 10 years of healthcare reform in China
por: Tao, Wenjuan, et al.
Publicado: (2020)

Integrated Disease Surveillance and Response (IDSR) strategy: current status, challenges and perspectives for the future in Africa
por: Fall, Ibrahima Socé, et al.
Publicado: (2019)

Public health engagement: new opportunities and challenges in 60 years of China’s health aid to Africa
por: Gao, Liangmin, et al.
Publicado: (2023)

Detection and Initial Response to a Type 2 Vaccine-Derived Poliovirus — Sichuan Province, China, 2019
por: Zhou, Jiushun, et al.
Publicado: (2020)

Real-world effectiveness and factors associated with effectiveness of inactivated SARS-CoV-2 vaccines: a systematic review and meta-regression analysis
por: Xu, Shiyao, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_ol48fjmne43fvchv4adt2jsvce